Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. (NASDAQ:ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Amtech reported quarterly sales of $27.70 million, missing the analyst consensus estimate of $34.50 million. The company anticipated first-quarter revenue to be between $21 million and $24 million, versus the $34.15 million estimate.

Benchmark analyst Mark Miller downgraded Amtech Systems from Buy to Hold.

Amtech Systems shares fell 30.6% to $4.16 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Freight Technologies, Inc. (NASDAQ:FRGT) shares jumped 322% to $1.14 after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.
• SRIVARU Holding Limited (NASDAQ:SVMH) rose 74.8% to $0.7000.
• XBP Europe Holdings, Inc. (NASDAQ:XBP) shares gained 49% to $8.46 after declining around 20% on Wednesday.
• TPI Composites, Inc. (NASDAQ:TPIC) rose 46% to $3.1350 as the company announced refinancing transaction with Oaktree, significantly strengthening company’s liquidity position and enhancing financial flexibility.
• Nxu, Inc. (NASDAQ:NXU) rose 43.6% to $0.0280 after the company signed a letter of intent outlining investment in Lynx Motors.
• Canterbury Park Holding Corporation (NASDAQ:CPHC) rose 31% to $18.70.
• View, Inc. (NASDAQ:VIEW) gained 29% to $5.14.
• Hanryu Holdings, Inc. (NASDAQ:HRYU) gained 27.1% to $1.3850 after jumping 28% on Wednesday.
• Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares climbed 23.2% to $1.8603. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.
• Redfin Corporation (NASDAQ:RDFN) gained 21.8% to $10.26.
• Codexis, Inc. (NASDAQ:CDXS) shares surged 20.5% to $2.5184. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.
• Vista Gold Corp. (NYSE:VGZ) gained 20% to $0.4010. Vista Gold announced a $20 million royalty with Wheaton Precious Metals Corp. on Mt Todd.
• Altice USA, Inc. (NYSE:ATUS) rose 18.8% to $2.4950.
• Sunnova Energy International Inc. (NYSE:NOVA) gained 18.3% to $14.09.
• Wayfair Inc. (NYSE:W) rose 17.3% to $66.75.
• Sunrun Inc. (NASDAQ:RUN) gained 16.7% to $17.42.
• Blend Labs, Inc. (NYSE:BLND) surged 16.7% to $2.1950. Blend Labs Head of Finance and Admin. Amir Jafari acquired a total of 12,610 shares at an average price of $1.22.
• Moderna, Inc. (NASDAQ:MRNA) rose 15.8% to $91.14. Moderna and Merck & Co announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with Keytruda in patients with resected high-risk melanoma (stage III/IV) following complete resection.
• VCI Global Limited (NASDAQ:VCIG) gained 15.4% to $2.62 after its financial technology arm, Accuventures Sdn Bhd, agreed to acquire the Malaysian digital platform EVOLET.
• Pacific Biosciences of California, Inc. (NASDAQ:PACB) surged 14.2% to $10.12. Stephens & Co. initiated coverage on Pacific Biosciences with an Overweight rating and announced a price target of $11.
• Alector, Inc. (NASDAQ:ALEC) rose 14.8% to $7.92. Stifel upgraded Alector from Hold to Buy and raised the price target from $8 to $15.
• Opendoor Technologies Inc. (NASDAQ:OPEN) gained 14.4% to $4.71.
• Enphase Energy, Inc. (NASDAQ:ENPH) rose 13.6% to $122.22.
• Plug Power Inc. (NASDAQ:PLUG) gained 12.7% to $4.8550.
• Alcoa Corporation (NYSE:AA) gained 11% to $28.84. Alcoa received approval for continued mining in Western Australia.
• RH (NYSE:RH) gained 7.3% to $304.60.

Losers

• Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) shares dipped 87.3% to $0.9861. Reneo Pharmaceuticals said its pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoint.
• Mynd.ai, Inc. (NYSE:MYND) fell 53.1% to $2.71.
• Cepton, Inc. (NASDAQ:CPTN) fell 24.2% to $3.01 after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast. Craig-Hallum downgraded Cepton from Buy to Hold.
• Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) declined 20.7% to $49.81 after the company announced it was informed of a negative trend vote on the marketing authorization application for pegcetacoplan.
• NextCure, Inc. (NASDAQ:NXTC) fell 20.7% to $1.15 after the company issued year-end clinical pipeline updates.
• MIND Technology, Inc. (NASDAQ:MIND) dipped 19.4% to $4.7414 following weak quarterly results.
• Aditxt, Inc. (NASDAQ:ADTX) fell 16.4% to $5.26.
• Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares fell 15.1% to $3.3450. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.
• NextPlay Technologies, Inc. (NASDAQ:NXTP) shares fell 11.4% to $1.3905 after jumping 68% on Wednesday.
• Regis Corporation (NYSE:RGS) shares fell 9.9% to $8.39. NYSE will begin delisting proceedings against Regis Corp.
• ABM Industries Incorporated (NYSE:ABM) dipped 9.5% to $47.33. ABM recently reported better-than-expected fourth-quarter financial results and issued guidance.
• Intensity Therapeutics, Inc. (NASDAQ:INTS) shares fell 9.4% to $8.94 after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.
• AerSale Corporation (NASDAQ:ASLE) shares fell 8% to $13.60. AerSale priced its secondary offering of 4 million common shares.
• B. Riley Financial, Inc. (NASDAQ:RILY) fell 7.6% to $19.95.
• Adobe Inc. (NASDAQ:ADBE) fell 6.2% to $585.55. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.

Now Read This: 'Wait For A Pullback — You're Late To The Party': Jim Cramer Says About This Tech Stock